...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Polytetrafluoroethylene-covered retrievable expandable nitinol stents for malignant esophageal obstructions: Factors influencing the outcome of 270 patients
【24h】

Polytetrafluoroethylene-covered retrievable expandable nitinol stents for malignant esophageal obstructions: Factors influencing the outcome of 270 patients

机译:聚四氟乙烯覆盖的可回收可膨胀镍钛合金覆膜支架用于食道恶性梗阻:影响270例患者预后的因素

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE. The purpose of this study was to evaluate the clinical effectiveness of polytetrafluoroethylene (PTFE) - covered retrievable expandable nitinol stents in patients with malignant esophageal strictures and to identify prognostic factors associated with clinical outcomes. MATERIALS AND METHODS. From 2001 to 2010, 320 PTFE-covered stents were placed in 270 patients. Technical and clinical success, complications, survival, and stent patency were measures of clinical effectiveness. The relationships among complications and age, sex, stricture location, stricture length, chemotherapy alone, chemoradiotherapy, and malignancy source were examined. Independent prognostic factors of overall survival and stent patency were identified. RESULTS. Stent placement and removal were technically successful and tolerated without procedural complications, and 98% of patients achieved clinical success. The complication rate was 30%. Two removed stents exhibited covering membrane separation. Chemotherapy was associated with increased stent migration (p = 0.002). Stricture location and chemoradiotherapy were associated with esophagorespiratory fistula development (p = 0.033 and p < 0.001, respectively). Median and mean survival periods were 114 days (95% CI, 102-126 days) and 166 days (138-193 days). Chemotherapy and chemoradiotherapy were independent prognostic factors for survival (p = 0.050 and p = 0.032, respectively). The median and mean stent patency periods were 60 days (41-79 days) and 90 days (71-108 days). Chemoradiotherapy was the only independent prognostic factor for stent patency (p = 0.012). CONCLUSION. The PTFE-covered stents were clinically effective. Membrane degradation was not evident, although 0.7% of the patients experienced covering membrane separation. Chemotherapy was associated with increased migration and prolonged survival. Chemoradiotherapy was associated with increased esophagorespiratory fistula formation and decreased stent patency.
机译:目的。这项研究的目的是评估聚四氟乙烯(PTFE)覆盖的可取式可膨胀镍钛合金支架在食管恶性狭窄患者中的临床疗效,并确定与临床结局相关的预后因素。材料和方法。从2001年到2010年,在270位患者中放置了320个PTFE覆膜支架。技术和临床的成功率,并发症,生存率和支架通畅是衡量临床有效性的指标。检查了并发症与年龄,性别,狭窄部位,狭窄长度,单纯化疗,放化疗和恶性肿瘤来源之间的关系。确定了总生存率和支架通畅性的独立预后因素。结果。支架置入和移除在技术上是成功的,并且可以耐受,没有手术并发症,并且98%的患者取得了临床成功。并发症发生率为30%。两个移出的支架表现出覆盖膜分离。化学疗法与支架迁移增加相关(p = 0.002)。严格的位置和放化疗与食管呼吸道瘘管的发生有关(分别为p = 0.033和p <0.001)。中位生存期和平均生存期分别为114天(95%CI,102-126天)和166天(138-193天)。化学疗法和放化疗是生存的独立预后因素(分别为p = 0.050和p = 0.032)。中位数和平均支架通畅期为60天(41-79天)和90天(71-108天)。化学放疗是支架通畅的唯一独立预后因素(p = 0.012)。结论。 PTFE覆膜支架在临床上是有效的。膜降解不明显,尽管0.7%的患者经历了膜分离。化学疗法与迁移增加和生存期延长有关。化学放疗与食管呼吸道瘘管形成增加和支架通畅性降低有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号